IMMU-32. RNA-NANOPARTICLE VACCINES MEDIATE T CELL TRAFFICKING NECESSARY FOR BBB PASSAGE AND ANTI-GLIOMA IMMUNE RESPONSE

BACKGROUND: The blood-brain barrier (BBB) remains a potent obstacle for development of new therapies against glioblastoma (GBM). While activated T cells can cross the BBB, immunotherapy has yet to be fully unlocked for malignant brain tumors due their heterogeneity and immunosuppressive microenviron...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Mendez-Gomez, Hector, Wummer, Brandon, Grippin, Adam, Weidert, Frances, Huang, Jianping, Deleyrolle, Loic, Mitchell, Duane, Sayour, Elias
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847633/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.524
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares